In April of this year, Takeda Pharmaceutical, Japan’s largest drug company purchased Millennium Pharmaceuticals, one of the earliest American genomics companies for nearly $9 billion providing Takeda an entry into the cancer-drug market. During this off-the-record discussion, topics will include:
- Important criteria each company sought in a strategic partner
- Communicating effectively through cultural differences
- Lessons learned during the due diligence process
- Approach for successful integration of the two companies
Presenters included:
- Gabor Garai, Co-Chair, Life Sciences Industry Team, Foley
- Dr. Daniel Curran, Vice President, Corporate Development, Millennium Pharmaceuticals Inc.
- Catherine Sazdanoff, Vice President, Global Licensing, Takeda Pharmaceuticals North America, Inc.
Related Insights
27 May 2025
Events
The RIF Roadmap: Tools and Tactics for a Smooth and Compliant Transition
Join us for an insightful discussion on proactive workforce planning in today's dynamic economic and regulatory landscape.
16 May 2025
Manufacturing Industry Advisor
Reese’s Law: The Evolving Regulatory and Enforcement Landscape for Consumer Products Containing Button Cell or Coin Batteries
Over the past year, manufacturers, importers, distributors, and retailers of consumer products containing button cell and coin batteries (or products intended to contain them) have continued to adapt to the requirements of Reese’s Law and the Consumer Product Safety Commission’s corresponding enforcement efforts.
29 May 2025
Events
May 2025 Midwest Cyber Security Alliance Meeting | What Happens After a Breach: Practical Tips for the Notification Process
Join us on Thursday, May 29, 2025, at the next Midwest Cyber Security Alliance Meeting. Brandon Hollinder, Esq., and Adam Botter from Epiq will provide practical tips and insights on organizing the data mining and subsequent notification process after a cybersecurity breach.